NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Cancer Diagnostics



Markers distinguish primary ovarian tumors from metastatic colorectal cancer



March 17th, 2005

Three immunohistochemical markers expressed in colonic adenocarcinoma help differentiate ovarian tumors from metastatic colorectal cancer, Emory University Hospital pathologists report.

"Distinguishing primary ovarian carcinoma, particularly endometrioid and mucinous subtypes, from metastatic colorectal carcinoma to the ovary is often difficult on histologic examination alone. Recently, three immunohistochemical markers - CDX2, a homeobox gene encoding an intestine-specific transcription factor; alpha-methylacyl-CoA racemase (AMACR/P504S), a mitochondrial and peroxisomal enzyme with fairly restricted expression in selective tumors; and beta-catenin, an adenomatous...


Source: Women's Health Weekly (2005-03-17)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login